BeOne Medicines AG ONC
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 208.16% | 151.28% | 17,802.13% | 143.79% | 202.88% |
| Total Depreciation and Amortization | 4.45% | 30.33% | 24.57% | -29.81% | -49.01% |
| Total Amortization of Deferred Charges | 1,435.33% | -72.31% | 48.51% | 30.60% | 29.60% |
| Total Other Non-Cash Items | -5.78% | -9.95% | 38.56% | -22.67% | 30.06% |
| Change in Net Operating Assets | -169.21% | 1,202.99% | -142.41% | 967.10% | -23.34% |
| Cash from Operations | 26.37% | 75.58% | 356.73% | 455.28% | 113.70% |
| Capital Expenditure | 26.85% | 37.31% | 27.69% | 59.43% | 64.02% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 50.84% | 3.96% | 92.80% | 27.73% | -424.23% |
| Cash from Investing | 27.43% | 25.90% | 62.68% | 59.05% | 63.20% |
| Total Debt Issued | -- | -100.00% | -27.25% | 58.63% | -- |
| Total Debt Repaid | -83.95% | 85.23% | 95.69% | -40.64% | -19.71% |
| Issuance of Common Stock | 36.69% | -66.67% | -62.32% | 118.79% | 396.42% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -100.01% | -- | -- | -- | -- |
| Cash from Financing | -89.37% | -117.28% | 303.19% | 2,243.07% | 7,491.79% |
| Foreign Exchange rate Adjustments | 6.00% | -15.51% | 455.17% | 144.79% | -65.06% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -55.78% | 67.22% | 325.39% | 768.32% | 1,286.91% |